Swissmedic
REGULATORY UPDATE
ElViS 2.0
Published: 9/4/2026Detected: 9/4/2026
Summary preview
ElViS 2.0 appears to be a Swiss regulatory update focused on a system/process commonly used for regulatory interactions, but the provided document content does not include actionable details on requirements, timelines…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free account#Swissmedic
#ElViS 2.0
#regulatory portal
#submission workflow
#dossier
Official Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”10/1/2026
- Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances10/1/2026
- Revision of the Guidance document Authorisation Biosimilar10/1/2026
- Swissmedic Portal Release – New Features Available from 23 September 20269/24/2026
- I-SMI.TI.22e Notifications according to Article 41, MPLO9/23/2026